54
Total Mentions
51
Documents
440
Connected Entities
Surname reference in Epstein-related documents
The documents primarily reference 'Daubert' in the context of Daubert motions, legal challenges to the admissibility of expert witness testimony, under Federal Rule of Evidence 702, and cite the case *Daubert v. Merrell Dow Pharmaceuticals, Inc.*. Mentions relate to legal strategy and preparation within the context of the case.
Daubert appears in discussions regarding legal motions and strategies, specifically concerning the admissibility of expert witness testimony. Several emails discuss 'Daubert motions', with attachments containing drafts and revisions of these motions. These motions appear to be related to precluding certain expert witnesses, such as Dr. Dietz and Dr. Loftus. One email mentions testimony in a 'Daubert Hearing'. Ghislaine Maxwell, Dietz, Rocchio, Loftus, and Prince Andrew are listed as top connections, sharing documents related to these legal discussions.

Perversion of Justice: The Jeffrey Epstein Story
Julie K. Brown
Investigative journalism that broke the Epstein case open

Filthy Rich: The Jeffrey Epstein Story
James Patterson
Bestselling account of Epstein's crimes and network

Relentless Pursuit: My Fight for the Victims of Jeffrey Epstein
Bradley J. Edwards
Victims' attorney's firsthand account
EFTA01652881
Daubed motion seeking to exclude expert testimony. On June 12, the Court granted the Class's motion for class certification and denied Defendant's Daubert motion as moot. Also in May 2023, the Parties agreed to engage in mediation. On May 30, 2023, the Settling Parties participated in a confidential m
d to dismiss both the initial and amended complaint, resisted discovery, took extensive discovery itself of the Plaintiff and our witnesses, filed a Daubert motion, and opposed class certification. B. Relevant Firm Experience 12. BSF has a strong record of successfully and diligently representing plai
EFTA00087220
od's operation, and whether the method is accepted by the expert community. United States v. Kidd, 385 F. Supp. 3d 259, 263 (S.D.N.Y. 2019) (citing Daubert v. Merrell Dow Phanns., Inc., 509 U.S. 579, 593-94 (1993)). But Rule 702 ultimately sets a "liberal" and "permissive" standard of admissibility. N
5 (2d Cir. 2017). To determine whether an expert's method is reliable, the Court considers the non-exhaustive list provided by the Supreme Court in Daubert, including whether the expert's method has been tested, whether it has been subjected to peer review, the rate of error, standards controlling the m
5 (2d Cir. 2017). To determine whether an expert's method is reliable, the Court considers the non-exhaustive list provided by the Supreme Court in Daubert, including whether the expert's method has been tested, whether it has been subjected to peer review, the rate of error, standards controlling the m
Page: EFTA00014702 →od's operation, and whether the method is accepted by the expert community. United States v. Kidd, 385 F. Supp. 3d 259, 263 (S.D.N.Y. 2019) (citing Daubert v. Merrell Dow Phanns., Inc., 509 U.S. 579, 593-94 (1993)). But Rule 702 ultimately sets a "liberal" and "permissive" standard of admissibility. N
Page: EFTA00014702 →t is the Defense's motion to exclude the Government's expert witness, Dr. Lisa Rocchio, pursuant to Federal Rule of Evidence 702 and the standard in Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). Dkt. No. 386. The Government filed a response brief, Dkt. No. 397, and Defendant filed a
Page: EFTA00016471 →ctly you're looking for, I'd be happy to recommend someone who might be a better fit. With that being said, I just testified earlier this week in a Daubert Hearing for Federal Prosecutor . I'm sure that you might find the hearing transcript of interest at a minimum, and it sheds light in the content
Page: EFTA00020878 →utting in so much work over the last few days to help us keep out Dr. Hall. From: Sent: Sunda November 14, 2021 11:41 PM To: Cc: Subject: Second Daubert Motion Hi Chiefs, I hope you had a nice weekend! Attached is our second Doubert motion for your review. It is due tomorrow. Thanks, Assistant Uni
Page: EFTA00023414 →From: "a" To: : 1.1NIT' ,MEMI. )i Subject: RE: Daubert motion Date: Mon, 08 Nov 2021 03:03:42 +0000 Attachments: Motion_to_preclude_Dietz_and_Loflus_v5.doex Hi all, Here's a version that incorporates
Page: EFTA00018897 →ives and reviews the documents they have in mind. Doing so, however, would almost certainly lead to mid-trial Dauber! briefing, possibly a mid-trial Daubert hearing, and late-breaking rebuttal expert notice by the Government. The better course is to require the defense to identify, immediately, the docu
Page: EFTA00024980 →ndant's motion under Federal Rule of Evidence 412, Dkt. No. 378, the Defendant's motion in limine to exclude under Federal Rule of Evidence 702 and Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), Dkt. No. 386, and the other outstanding issues that overlap with these two motions as di
Page: EFTA00027649 →ndant's motion under Federal Rule of Evidence 412, Dkt. No. 378, the Defendant's motion in limine to exclude under Federal Rule of Evidence 702 and Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), Dkt. No. 386, and the other outstanding issues that overlap with these two motions as di
Page: EFTA00027654 →endant's motion under Federal Rule of Evidence 412, Dkt. No. 378, the Defendant's motion in limine to exclude under Federal Rule of Evidence 702 and Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), Dkt. No. 386, and the other outstanding issues that overlap with these two motions as di
Page: EFTA00028165 →know and I'll ask to revise. Thanks. From: Sent: Sunday, November 7, 20213:00 PM To: Subject: RE: joint letter Can we all dial into the call on Daubert and then talk about that? From: Sent: Sunday, November 7, 2021 2:57 PM To: Subject: RE: joint letter I'm actually thinking maybe we should all t
Page: EFTA00028209 →for everyone's excellent work on this—really impressive stuff. From: Sent: Sunday, November 7, 2021 10:04 PM To: (USANYS) c sc M > Subject: RE: Daubert motion Hi all, Here's a version that incorporates the Loftus section. The plan is to have a draft in the chiefs' inbox when they wake up, so if fo
Page: EFTA00028211 →help incorporate any of their comments/do other revisions/etc. From: I Sent: Sunday, November 7, 202111:20 PM To: ) >; (USANYS) Subject: RE: Daubert motion > Here are one or two very small things. This looks great to me, and I defer to you guys on the bigger picture stuff, since you're closer t
Page: EFTA00028212 →indows: • Anytime after 12 p.m. on June 14th • Anytime before 12 p.m. June 15th We chatted as a team, and we're going to be working on the RTC and a Daubert motion over the summer, as we discussed. Time permitting, we're likely going to work ahead on a 404(b) motion as well. Thanks, Assistant United St
Page: EFTA00028705 →ng today Team, We have three things due today: (1) the bail opposition, (2) the letter saying we don't object to preliminary instructions, and (3) Daubert. Looks like items 1 and 2 are done, so when we talk this morning let's discuss a timetable for getting stuff docketed. I think and I should probabl
Page: EFTA00028214 →evening after 7:30 - would that work for ou? On Sun, Oct 31, 2021 at 7:53 PM (USANYS) c ) wrote: Than s or your time earlier today. I'm attaching Daubert-related briefing in the case. After you have had a chance to review, let's find a time to speak on the phone. Please let us know some times that wor
Page: EFTA00030643 →From: in" alMIE> To: ' SS)" a, (USANYS)" Cc: ir I Subject: MIL opps - Daubert Date: Fri, 22 Oct 2021 19:39:14 +0000 Attachments: Daubert_v3.docx (USANYS)" Had Attached is a draft response to their Daubert motion. You'll se
Page: EFTA00032721 →EFTA00040107
t is the Defense's motion to exclude the Government's expert witness, Dr. Lisa Rocchio, pursuant to Federal Rule of Evidence 702 and the standard in Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). Dkt. No. 386. The Government filed a response brief, Dkt. No. 397, and Defendant filed a
From: To: Cc: Subject: RE: Second Daubert Motion Date: Mon, 15 Nov 2021 20:38:09 +0000 Attachments: Motion_to_precludeyall_o_al_v3_JME.docx Thanks guys. IM's comments are in the attached.
Page: EFTA00023416 →
Ghislaine Maxwell
PersonBritish socialite and sex trafficker, daughter of Robert Maxwell, accomplice of Jeffrey Epstein

Jeffrey Epstein
PersonAmerican sex offender and financier (1953–2019)

Prince Andrew
PersonThird child of Queen Elizabeth II and Prince Philip, Duke of Edinburgh (born 1960)
Rocchio
PersonSurname reference in Epstein-related documents

United States
LocationCountry located primarily in North America
Loftus
PersonAmbiguous surname reference in Epstein documents
Dietz
PersonSurname reference in Epstein-related documents

Supreme Court
OrganizationHighest court of jurisdiction in the US

Russell Simmons
PersonAmerican entrepreneur and record executive
Southern District
LocationFederal judicial district in New York City
Jeffrey Pagliuca
PersonAmerican attorney, defense lawyer for Ghislaine Maxwell during her criminal trial
Lisa Rocchio
PersonPerson referenced in documents

Harvey Weinstein
PersonAmerican film producer and sex offender (born 1952)

Bloomberg L.P.
OrganizationAmerican privately held financial, software, data, and media company

Southern District of New York
OrganizationFederal judicial district covering Manhattan and surrounding areas

ALISON J. NATHAN
OrganizationU.S. federal judge (person name misclassified as organization)
Merrell Dow Pharmaceuticals, Inc.
OrganizationOrganization referenced in documents
E.E.O.C. v. Bloomberg L.P.
OrganizationOrganization referenced in documents
Second Circuit
OrganizationU.S. Court of Appeals for the Second Circuit

Ryan Hall
PersonAmerican mixed martial artist and Brazilian Jiu-Jitsu practitioner